129 related articles for article (PubMed ID: 37772388)
21. Dishevelled proteins and CYLD reciprocally regulate each other in CML cell lines.
Çalışkan C; Pehlivan M; Yüce Z; Sercan O
Mol Biol Rep; 2017 Oct; 44(5):391-397. PubMed ID: 28840581
[TBL] [Abstract][Full Text] [Related]
22. Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma.
Suenaga N; Kuramitsu M; Komure K; Kanemaru A; Takano K; Ozeki K; Nishimura Y; Yoshida R; Nakayama H; Shinriki S; Saito H; Jono H
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635163
[TBL] [Abstract][Full Text] [Related]
23. SKA3 promotes glioblastoma proliferation and invasion by enhancing the activation of Wnt/β-catenin signaling via modulation of the Akt/GSK-3β axis.
Li C; Yang J; Lei S; Wang W
Brain Res; 2021 Aug; 1765():147500. PubMed ID: 33895155
[TBL] [Abstract][Full Text] [Related]
24. Tumor suppressor role of sFRP‑4 in hepatocellular carcinoma via the Wnt/β‑catenin signaling pathway.
Wu Q; Xu C; Zeng X; Zhang Z; Yang B; Rao Z
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760186
[TBL] [Abstract][Full Text] [Related]
25. Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
Shinriki S; Jono H; Maeshiro M; Nakamura T; Guo J; Li JD; Ueda M; Yoshida R; Shinohara M; Nakayama H; Matsui H; Ando Y
J Pathol; 2018 Mar; 244(3):367-379. PubMed ID: 29235674
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Proliferation by Knockdown of Transmembrane (TMEM) 168 in Glioblastoma Cells via Suppression of Wnt/β-Catenin Pathway.
Xu J; Su Z; Ding Q; Shen L; Nie X; Pan X; Yan A; Yan R; Zhou Y; Li L; Lu B
Oncol Res; 2019 Jul; 27(7):819-826. PubMed ID: 30940290
[TBL] [Abstract][Full Text] [Related]
27. Sohlh1 suppresses glioblastoma cell proliferation, migration, and invasion by inhibition of Wnt/β-catenin signaling.
Liu X; Gao Q; Zhao N; Zhang X; Cui W; Sun J; Fu J; Hao J
Mol Carcinog; 2018 Apr; 57(4):494-502. PubMed ID: 29240260
[TBL] [Abstract][Full Text] [Related]
28. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
29. FOXO3a inhibits nephroblastoma cell proliferation, migration and invasion, and induces apoptosis through downregulating the Wnt/β‑catenin signaling pathway.
Qian C; Liu Q
Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34515328
[TBL] [Abstract][Full Text] [Related]
30. Cancer‑associated fibroblast‑derived LRRC15 promotes the migration and invasion of triple‑negative breast cancer cells via Wnt/β‑catenin signalling pathway regulation.
Yang Y; Wu H; Fan S; Bi Y; Hao M; Shang J
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34726255
[TBL] [Abstract][Full Text] [Related]
31. MiR-106b promotes therapeutic antibody expression in CHO cells by targeting deubiquitinase CYLD.
Xu C; Han Q; Zhou Q; Zhang L; Wu P; Lu Y; Si Y; Ma T; Ma B; Zhang B
Appl Microbiol Biotechnol; 2019 Sep; 103(17):7085-7095. PubMed ID: 31292678
[TBL] [Abstract][Full Text] [Related]
32. FGD5-AS1 facilitates glioblastoma progression by activation of Wnt/β-catenin signaling via regulating miR-129-5p/HNRNPK axis.
Wu L; Zhu X; Song Z; Guo M; Liang J; Yan D
Life Sci; 2020 Sep; 256():117998. PubMed ID: 32585241
[TBL] [Abstract][Full Text] [Related]
33. FRAT1 promotes the angiogenic properties of human glioblastoma cells via VEGFA.
Yang B; Liu D; Ren YQ; Sun YQ; Zhang JP; Wang XG; Wu YQ; Wang SL; Guo SH; Guo G
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35059733
[TBL] [Abstract][Full Text] [Related]
34. circMMD reduction following tumor treating fields inhibits glioblastoma progression through FUBP1/FIR/DVL1 and miR-15b-5p/FZD6 signaling.
Xu S; Luo C; Chen D; Tang L; Cheng Q; Chen L; Liu Z
J Exp Clin Cancer Res; 2023 Mar; 42(1):64. PubMed ID: 36932454
[TBL] [Abstract][Full Text] [Related]
35. Cylindromatosis Is Required for Survival of a Subset of Melanoma Cells.
La T; Jin L; Liu XY; Song ZH; Farrelly M; Feng YC; Yan XG; Zhang YY; Thorne RF; Zhang XD; Teng L
Oncol Res; 2020 Sep; 28(4):385-398. PubMed ID: 32252875
[TBL] [Abstract][Full Text] [Related]
36. FRZB knockdown upregulates β-catenin activity and enhances cell aggressiveness in gastric cancer.
Qin S; Zhang Z; Li J; Zang L
Oncol Rep; 2014 May; 31(5):2351-7. PubMed ID: 24676361
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of miR‑194 suppresses the Wnt/β‑catenin signalling pathway in gastric cancer.
Peng Y; Zhang X; Lin H; Deng S; Huang Y; Qin Y; Feng X; Yan R; Zhao Y; Cheng Y; Wei Y; Wang J; Chen W; Fan X; Ashktorab H; Smoot D; Meltzer SJ; Li S; Zhang Z; Jin Z
Oncol Rep; 2018 Dec; 40(6):3323-3334. PubMed ID: 30542715
[TBL] [Abstract][Full Text] [Related]
38. High DKK3 expression related to immunosuppression was associated with poor prognosis in glioblastoma: machine learning approach.
Han MH; Min KW; Noh YK; Kim JM; Cheong JH; Ryu JI; Won YD; Koh SH; Myung JK; Park JY; Kwon MJ
Cancer Immunol Immunother; 2022 Dec; 71(12):3013-3027. PubMed ID: 35599254
[TBL] [Abstract][Full Text] [Related]
39. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease.
van Andel H; Kocemba KA; de Haan-Kramer A; Mellink CH; Piwowar M; Broijl A; van Duin M; Sonneveld P; Maurice MM; Kersten MJ; Spaargaren M; Pals ST
Oncogene; 2017 Apr; 36(15):2105-2115. PubMed ID: 27775078
[TBL] [Abstract][Full Text] [Related]
40. Long non‑coding RNA 01614 hyperactivates WNT/β‑catenin signaling to promote pancreatic cancer progression by suppressing GSK‑3β.
Chen LJ; Wu L; Wang W; Zhai LL; Xiang F; Li WB; Tang ZG
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 35929518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
